Danaher Corporation (NYSE:DHR) has earned a consensus rating of “Buy” from the eighteen analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, thirteen have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $92.39.

Several equities analysts recently issued reports on the company. Royal Bank Of Canada reissued a “sector perform” rating and set a $88.00 target price (down previously from $89.00) on shares of Danaher Corporation in a research note on Friday, April 21st. BidaskClub lowered Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 25th. Zacks Investment Research lowered Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Citigroup Inc. set a $96.00 target price on Danaher Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. Finally, Janney Montgomery Scott lowered Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th.

Shares of Danaher Corporation (DHR) traded down 1.42% during trading on Tuesday, hitting $80.27. The stock had a trading volume of 2,997,069 shares. The stock has a market cap of $55.76 billion, a price-to-earnings ratio of 25.62 and a beta of 1.03. The company’s 50 day moving average price is $83.66 and its 200 day moving average price is $84.23. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01.

Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same quarter in the prior year, the company earned $0.90 EPS. Danaher Corporation’s revenue was up 6.3% on a year-over-year basis. Equities research analysts expect that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

WARNING: “Danaher Corporation (DHR) Receives Average Rating of “Buy” from Analysts” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/08/danaher-corporation-dhr-receives-average-rating-of-buy-from-analysts.html.

In other news, SVP Angela S. Lalor sold 10,815 shares of the stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total value of $910,190.40. Following the transaction, the senior vice president now owns 39,020 shares in the company, valued at approximately $3,283,923.20. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the transaction, the insider now owns 155,520 shares in the company, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 38,623 shares of company stock worth $3,206,426. Company insiders own 12.20% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its position in Danaher Corporation by 3.9% in the first quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock worth $3,503,962,000 after buying an additional 1,530,015 shares during the last quarter. BlackRock Inc. increased its position in Danaher Corporation by 2,530.9% in the first quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock worth $3,247,398,000 after buying an additional 36,524,795 shares during the last quarter. FMR LLC increased its position in Danaher Corporation by 0.3% in the first quarter. FMR LLC now owns 19,441,167 shares of the conglomerate’s stock worth $1,662,803,000 after buying an additional 53,429 shares during the last quarter. Parnassus Investments CA increased its position in Danaher Corporation by 15.3% in the first quarter. Parnassus Investments CA now owns 8,622,528 shares of the conglomerate’s stock worth $712,738,000 after buying an additional 1,143,284 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its position in Danaher Corporation by 0.7% in the first quarter. Bank of New York Mellon Corp now owns 7,645,818 shares of the conglomerate’s stock worth $653,946,000 after buying an additional 50,673 shares during the last quarter. Institutional investors and hedge funds own 76.56% of the company’s stock.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Analyst Recommendations for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.